Skip to content

Eye-acupuncture with rehabilitation therapy for stroke

Clinical optimization study for eye-acupuncture with rehabilitation therapy in hemiplegia caused by stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027835
Enrollment
Unknown
Registered
2019-11-30
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia for stroke in recovery stage

Interventions

Sponsors

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) aged from 30 to 75 years; (2) meet the diagnostic criteria of cerebral infarction or cerebral hemorrhage in western medicine; (3) meet the diagnostic criteria and staging criteria of stroke in traditional Chinese medicine; (4) cerebral infarction or cerebral hemorrhage occurred within 3 months; (5) improved BARTHEL index score =3; (6) the patient and his/her family members voluntarily agree to participate in this clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) lack of clear imaging evidence, such as CT or MRI, or lack of sufficient imaging evidence to determine the diagnosis; (2) stroke type: patients with progressive stroke and cerebral hemorrhage after cerebral infarction.Patients with impaired consciousness; (3) patients with mild illness;For patients with mild cerebral stroke or neurological impairment, the score of modified BARTHEL index was >=70.Non-disabling or rapidly improving patients with small strokes, including transient ischemic attack (TIA), reversible ischemic attack (RIND), etc.; (4) patients with acute stage vascular opening (such as thrombolysis, arterial thrombectomy, super-early thrombus aspiration and stenting, etc.); (5) those with bleeding tendency; Severe bleeding occurred within 3 months; (6) patients with severe cardiac insufficiency, patients with atrial fibrillation, patients with cardiac valvular disease or patients after cardiac valve replacement; (7) patients with other diseases that affect limb movement function, and patients with limb movement dysfunction caused by claudication, rheumatoid arthritis and gouty arthritis before treatment.

Design outcomes

Primary

MeasureTime frame
Activies of Daily Living (ADL);The Fugl-Meyer Assessment (FMA);Resting state functional MRI (rs-fMRI);

Secondary

MeasureTime frame
TCM syndrome score;Water swallow test;Western aphasia scale;Montreal Cognitive Assessment;Brain fuctional remodeling associated protein-43(GAP-43);periinfarct microtubule-associated proteins gene (MAP-2);

Countries

China

Contacts

Public ContactPengqin Wang

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

23318199@163.com+86 18102457199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026